Embecta (EMBC) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29082K1051
Embecta Corp., listed on the NASDAQ under the ticker symbol EMBC, is a renowned medical device company dedicated to improving the quality of life for individuals with diabetes. Their comprehensive range of offerings includes pen needles, syringes, safety injection devices, and innovative digital tools designed to support diabetes management.
Specializing in providing solutions for diabetes care, Embecta Corp. serves a global market by supplying their products to wholesalers and distributors both in the United States and abroad. With a commitment to enhancing healthcare outcomes, the company's impactful contributions have been positively shaping the lives of diabetic individuals since its establishment in 1924.
Headquartered in Parsippany, New Jersey, Embecta Corp.'s mission-driven approach and continuous innovation set them apart as a leading force in the field of diabetes management. To discover more about their transformative products and initiatives, visit their website at https://www.embecta.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
EMBC Stock Overview
| Market Cap in USD | 589m |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| GiC SubIndustry | Health Care Supplies |
| TER | 0.00% |
| IPO / Inception | 2022-04-01 |
EMBC Stock Ratings
| Growth 5y | -5.84 |
| Fundamental | 8.20 |
| Dividend | 4.69 |
| Rel. Performance vs Sector | -10.86 |
| Analysts | 2.25/5 |
| Fair Price Momentum | 7.63 USD |
| Fair Price DCF | 20.01 USD |
EMBC Dividends
| Yield 12m | 5.84% |
| Yield on Cost 5y | 1.13% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
EMBC Growth Ratios
| Growth 12m | -64.13% |
| Growth Correlation 12m | -66% |
| Growth Correlation 3m | -83% |
| CAGR 5y | -53.53% |
| Sharpe Ratio 12m | -1.49 |
| Alpha vs SP500 12m | -81.32 |
| Beta vs SP500 5y weekly | 0.55 |
| ValueRay RSI | 54.54 |
| Volatility GJR Garch 1y | 48.61% |
| Price / SMA 50 | -14.84% |
| Price / SMA 200 | -34.17% |
| Current Volume | 416.1k |
| Average Volume 20d | 396.4k |
External Links for EMBC Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of May 09, 2024, the stock is trading at USD 10.27 with a total of 416,093 shares traded.
Over the past week, the price has changed by +1.38%, over one month by -15.40%, over three months by -41.57% and over the past year by -63.83%.
According to ValueRays Forecast Model, EMBC Embecta will be worth about 8.2 in May 2025. The stock is currently trading at 10.27. This means that the stock has a potential downside of -19.77%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 16.5 | 60.7 |
| Analysts Target Price | 16 | 55.8 |
| ValueRay Target Price | 8.2 | -19.8 |